Pain processing represents a highly complex field with significant variations arising from both biological (sex) and psychosocial (gender) factors, ...

The leading candidates for such genome-wide association studies (GWAS) are existing large-scale cohort and clinical studies that have collected rich sets of phenotype data. To support investigator ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

Charcot-Marie-Tooth disease type 2E (CMT2E) is a slow and progressive neuropathy characterized by axonal dysfunction. Its clinical phenotype includes muscle weakness and atrophy, sensory loss and ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Research underscores importance of both genetic and functional testing in diagnosing mitochondrial disorders, particularly ...

The following is a summary of "Treatment Sequencing in Inflammatory Bowel Disease: Towards Clinical Precision Medicine," published in the March 2025 issue of Best Practice & Research Clinical ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...